July 18, 2006
Barriers to Open Access in the Bio-pharmaceutical Field
FLOSS Methods in Biotechnology, by Andrea Glorioso
from First Monday, volume 11, number 7 (July 2006)
The United Nations Conference on Trade and Development (2002) Key issues in biotechnology urged that knowledge created in the realm of biotechnology should remain in the open access arena. This discussion in First Monday is "limited to a specific subfield — namely, the bio–pharmaceutical field — and to a limited set of players, i.e. profit–maximizing firms, with the desire to understand what are the obstacles and the options for a firm in use a “FLOSS model” in its research, development and commercialization processes".
According to Wikipedia, FLOSS stands for Free/Libre/Open-Source Software.
Posted by Katie Newman at July 18, 2006 10:24 AM